Nodular hyperplasia of the prostate gland
Jump to navigation
Jump to search
Nodular hyperplasia of the prostate gland | |
---|---|
Diagnosis in short | |
Nodular hyperplasia of the prostate gland. H&E stain. | |
| |
Synonyms | benign prostatic hyperplasia, benign prostatic hypertrophy (misnomer) |
| |
LM | stromal and/or glandular hyperplasia |
LM DDx | smooth muscle tumour of uncertain malignant potential, subtle prostate carcinoma |
Gross | enlarged prostate gland, nodularity |
Grossing notes | prostate chips, radical prostatectomy |
Site | prostate gland |
| |
Clinical history | old man |
Signs | hematuria, weak urine stream, incomplete urinary emptying, post-void dribbling, prolonged voiding, intermittency, hesitancy |
Symptoms | increased frequency of urination, straining |
Prevalence | very common, esp. elderly |
Blood work | +/-elevation of PSA (mild) |
Prognosis | benign |
Clin. DDx | other causes of hematuria (urothelial carcinoma, renal cell carcinoma, cystitis), other causes of obstruction (prostate carcinoma, urothelial carcinoma) |
Treatment | medical, TURP |
Nodular hyperplasia of the prostate gland, also benign prostatic hyperplasia (abbreviated BPH), is a common benign pathology of the prostate gland.
It is also known as prostatic nodular hyperplasia. Occasionally, it is referred to as benign prostatic hypertrophy; this is a misnomer. This pathology is not a hypertrophy.
General
- Very common.
- Incidence increases with age.
Clinical - mnemonic I WISH 2p:[1]
- Intermittency.
- Weak stream.
- Incomplete emptying.
- Straining.
- Hesitancy.
- Post-void dribbling.
- Prolonged voiding.
Others:
- Hematuria - common.[2]
Treatment:
Gross
- Enlargement of the prostate.
- Nodularity of the prostate.
Microscopic
Features:
- Stromal and/or glandular hyperplasia.
- Stromal component has small blood vessels.
Notes:
- Should not be diagnosed on core biopsy!
- One series suggests clinically relevant prostate cancer is seen in ~1.5% of resections for BPH.[4]
DDx:
- Urothelial carcinoma - significant nuclear atypia.
- Prostate carcinoma - especially low-grade.
- Prostatic stromal tumour of uncertain malignant potential - lacks small vessels.[5]
Images
Sign out
Urothelium present
Prostate Tissue, Transurethral Resection of Prostate (TURP): - Benign prostatic tissue with glandular and stromal proliferation. - Benign urothelial mucosa with inflammation. - NEGATIVE for malignancy.
Prostate Tissue, Transurethral Resection of Prostate (TURP): - Benign prostatic tissue. - Benign urothelial mucosa with mild inflammation and calcification. - NEGATIVE for malignancy.
Block letters
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): - BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION. - UROTHELIAL MUCOSA WITH A MILD LYMPHOCYTIC INFILTRATE. - NEGATIVE FOR MALIGNANCY.
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND URINARY BLADDER NECK: - BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION. - UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS. - NEGATIVE FOR MALIGNANCY.
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) AND URINARY BLADDER NECK: - BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION, AND FOCAL ACUTE AND CHRONIC INFLAMMATION. - UROTHELIUM WITH THE CHANGES OF CYSTITIS CYSTICA ET GLANDULARIS. - NEGATIVE FOR MALIGNANCY.
No urothelium present
PROSTATE GLAND, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): - BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION.
Post-TURP granuloma present
PROSTATE TISSUE, TRANSURETHRAL RESECTION OF THE PROSTATE (TURP): - BENIGN PROSTATIC TISSUE WITH GLANDULAR AND STROMAL PROLIFERATION WITH PROMINENT BLOOD VESSELS AND SQUAMOUS METAPLASIA. - PALISADING GRANULOMA WITH NECROTIC CORE, SEE COMMENT. - UROTHELIAL MUCOSA WITH A MILD INFLAMMATORY INFILTRATE. - NEGATIVE FOR MALIGNANCY. COMMENT: This is morphologically consistent with a post-TURP granuloma.
See also
References
- ↑ Shiau, Carolyn; Toren, Andrew (2006). Toronto Notes 2006: Comprehensive Medical Reference (Review for MCCQE 1 and USMLE Step 2) (22nd edition (2006) ed.). Toronto Notes for Medical Students, Inc.. pp. U5. ISBN 978-0968592861.
- ↑ Sharp, VJ.; Barnes, KT.; Erickson, BA. (Dec 2013). "Assessment of asymptomatic microscopic hematuria in adults.". Am Fam Physician 88 (11): 747-54. PMID 24364522.
- ↑ Westwood J, Geraghty R, Jones P, Rai BP, Somani BK (November 2018). "Rezum: a new transurethral water vapour therapy for benign prostatic hyperplasia". Ther Adv Urol 10 (11): 327–333. doi:10.1177/1756287218793084. PMC 6180381. PMID 30344644. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180381/.
- ↑ Skrzypczyk, MA.; Dobruch, J.; Nyk, L.; Szostek, P.; Szempliński, S.; Borówka, A. (2014). "Should all specimens taken during surgical treatment of patients with benign prostatic hyperplasia be assessed by a pathologist?". Cent European J Urol 67 (3): 227-32. doi:10.5173/ceju.2014.03.art2. PMID 25247076.
- ↑ Hansel, DE.; Herawi, M.; Montgomery, E.; Epstein, JI. (Jan 2007). "Spindle cell lesions of the adult prostate.". Mod Pathol 20 (1): 148-58. doi:10.1038/modpathol.3800676. PMID 17170745.